NCT07326501

Brief Summary

"Artificial intelligence (AI), including large language models and conversational tools, is increasingly being used in medical research. These tools may assist researchers at different stages of the scientific process, such as generating research ideas, reviewing the literature, analyzing data, writing manuscripts, and preparing articles for publication. While interest in AI is growing rapidly, there is still limited information on how these tools are actually perceived and used by leading medical researchers. This study aims to better understand the attitudes, perceptions, and self-reported uses of artificial intelligence among corresponding authors who have published in six major international medical journals. These authors play a key role in shaping scientific standards and editorial practices, and their views are essential to understanding how AI may influence the future of medical research. Participants are invited to complete an anonymous online questionnaire that asks about their familiarity with AI tools, how and when they use or plan to use them in the research process, the potential benefits they perceive, and the concerns or limitations they identify. The survey also explores participants' expectations regarding transparency, ethical guidance, and journal policies related to the use of artificial intelligence in scientific work.The study is observational and does not involve any medical intervention or collection of personal or health-related data. Participation is voluntary, and responses are fully anonymous.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
2mo left

Started Dec 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress74%
Dec 2025Jun 2026

Study Start

First participant enrolled

December 10, 2025

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

December 24, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

January 8, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 10, 2026

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Expected
Last Updated

January 8, 2026

Status Verified

December 1, 2025

Enrollment Period

3 months

First QC Date

December 24, 2025

Last Update Submit

December 24, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Self-reported attitudes regarding the use of artificial intelligence in the scientific research process

    Participants report their attitudes and perceptions regarding the use of artificial intelligence in the scientific research process through multiple-choice and Likert-scale items. Responses are analyzed descriptively; higher scores indicate more favorable attitudes toward the use of artificial intelligence.

    At the inclusion

  • Perceptions regarding the use of artificial intelligence in the scientific research process

    Participants report their attitudes and perceptions regarding the use of artificial intelligence in the scientific research process through multiple-choice and Likert-scale items. Responses are analyzed descriptively; higher scores indicate more favorable attitudes toward the use of artificial intelligence.

    At the inclusion

Secondary Outcomes (4)

  • Self-reported patterns of use, regarding artificial intelligence tools in scientific research and publishing

    At the inclusion

  • Perceived benefits regarding artificial intelligence tools in scientific research and publishing

    At the inclusion

  • Risk regarding artificial intelligence tools in scientific research and publishing

    At the inclusion

  • Expectations regarding artificial intelligence tools in scientific research and publishing

    At the inclusion

Study Arms (1)

Authors Survey Group

This label identifies the single cohort of participants, consisting of corresponding authors invited to complete the anonymous online survey. No comparison or control groups are included.

Other: observational survey

Interventions

This is an observational, non-interventional study based on an anonymous online questionnaire. No intervention is administered to participants.

Authors Survey Group

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of corresponding authors who have published scientific articles in leading international medical journals. Participants are identified through publicly available publication data from six major journals (The New England Journal of Medicine, The Lancet, JAMA, Nature, Science, and The BMJ) and are invited to participate via professional email addresses. The population includes adult researchers from diverse biomedical and medical disciplines, with no geographic restriction.

You may qualify if:

  • Participants without any disease, condition, or related symptoms are permitted to participate. This study is a non-clinical, observational survey focusing on attitudes and practices related to artificial intelligence in scientific research, not on health conditions.

You may not qualify if:

  • Authors who are not corresponding authors.
  • Students, residents, interns, or trainees without corresponding author status.
  • Individuals not involved in biomedical or medical research activities.
  • Individuals who decline to participate or do not complete the online questionnaire.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de NICE

Nice, Alpes Maritimes, 06000, France

Location

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 24, 2025

First Posted

January 8, 2026

Study Start

December 10, 2025

Primary Completion

March 10, 2026

Study Completion (Estimated)

June 30, 2026

Last Updated

January 8, 2026

Record last verified: 2025-12

Locations